About VIVOGENE
VIVOGENE is a company based in Chennai (India) founded in 2017. VIVOGENE offers products and services including Human stem cell derived supplements, Plant stem cell derived supplements, Rapid skin ECM, I-AAHD, and Bioinformatics Services. VIVOGENE operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Chennai, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Vivogene Life Sciences Llp
- Date of Incorporation 03 Aug, 2021
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VIVOGENE
VIVOGENE offers a comprehensive portfolio of products and services, including Human stem cell derived supplements, Plant stem cell derived supplements, Rapid skin ECM, I-AAHD, and Bioinformatics Services.
Supplements from human stem cells for cosmetic procedures.
Supplements from plant stem cells for skin care and antioxidants.
System for administering extra-cellular matrix for injury treatment.
Antimicrobial haemostat device for rapid wound control.
Reagents for molecular biology and immunology applications.
Support for drug discovery and custom molecule synthesis.
Funding Insights of VIVOGENE
Detailed funding history for VIVOGENE
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VIVOGENE
Investment portfolio details for VIVOGENE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VIVOGENE
Detailed financials for VIVOGENE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivogene Comparisons
Peer comparison for VIVOGENE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VIVOGENE
VIVOGENE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of VIVOGENE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivogene
Complete news archive for VIVOGENE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VIVOGENE
VIVOGENE was founded in 2017.
VIVOGENE is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
VIVOGENE was founded in 2017 and is based in Chennai, India. Operations focus on the biotechnology sector, with services encompassing custom synthesis of complex molecules, comprehensive literature searches, early-stage drug discovery, custom library synthesis, development of custom building blocks, novel route design, and contract research for stem cell therapies. These activities support pharmaceutical research and development needs.
VIVOGENE's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
VIVOGENE offers Human stem cell derived supplements, Plant stem cell derived supplements, Rapid skin ECM, I-AAHD, and 2 more products and services.